Characterization of a Family of Chimpanzee Adenoviruses and Development of Molecular Clones for Gene Transfer Vectors

Human Gene Therapy

Volumn 15, Issue 5, 2004, Pages 519-530

  Roy, Soumitra ^a   Gao, Guangping ^a   Lu, You ^a   Zhou, Xiangyang ^a   Lock, Martin ^a   Calcedo, Roberto ^a   Wilson, James M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 204 Wistar ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; NEUTRALIZING ANTIBODY; RABBIT ANTISERUM; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; CHIMPANZEE; DRUG DELIVERY SYSTEM; DRUG RESEARCH; FIBROBLAST CULTURE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HUMAN; HUMAN CELL; KIDNEY CELL CULTURE; KIDNEY FIBROSIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMID; POPULATION DIFFERENTIATION; SAMPLE; SERUM; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; ANIMALS; CELL LINE; CLONE CELLS; DNA, VIRAL; GENE DELETION; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEUTRALIZATION TESTS; PAN TROGLODYTES; RABBITS; SEQUENCE ANALYSIS, DNA; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; PAN TROGLODYTES;

EID: 2442487912     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340460745838     Document Type: Article

References (23)

1. BASNIGHT, M., Jr., ROGERS, N.G., GIBBS, C.J., Jr., and GAJDUSEK, D.C. (1971). Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants. Am. J. Epidemiol. 94, 166-171.
2. CASIMIRO, D.R., TANG, A., CHEN, L., FU, T.M., EVANS, R.K., DAVIES, M.E., FREED, D.C., HURNI, W., ASTE-AMEZAGA, J.M., GUAN, L., LONG, R., HUANG, L., HARRIS, V., NAWROCKI, D.K., MACH, H., TROUTMAN, R.D., ISOPI, L.A., MURTHY, K.K., RICE, K., WILSON, K.A., VOLKIN, D.B., EMINI, E.A., and SHIVER, J.W. (2003). Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77, 7663-7668.
3. FARINA, S.F., GAO, G.P., XIANG, Z.Q., RUX, J.J., BURNETT, R.M., ALVIRA, M.R., MARSH, J., ERTL, H.C., and WILSON, J.M. (2001). Replication-defective vector based on a chimpanzee adenovirus. J. Virol. 75, 11603-11613.
4. FITZGERALD, J.C., GAO, G.P., REYES-SANDOVAL, A., PAVLAKIS, G.N., XIANG, Z.Q., WLAZLO, A.P., GILES-DAVIS, W., WILSON, J.M., and ERTL, H.C. (2003). A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J. Immunol. 170, 1416-1422.
5. GAO, G.P., YANG, Y., and WILSON, J.M. (1996). Biology of adenoviral vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70, 8934-8943.
6. GAO, G., QU, G., BURNHAM, M.S., HUANG, J., CHIRMULE, N., JOSHI, B., YU, Q.C., MARSH, J.A., CONCEICAO, C.M., and WILSON, J.M. (2000). Purification of recombinant adeno-associated viral vectors by column chromatography and its performance in vivo. Hum. Gene Ther. 11, 2079-2091.
7. GAO, G.P., ZHOU, X., ALVIRA, M.R., TRAN, P., MARSH, J., LYND, K., XIAO, W., and WILSON, J.M. (2003). High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells. Gene Ther. 10, 1926-1930.
8. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
9. KREMER, E.J., BOUTIN, S., CHILLON, M., and DANOS, O. (2000). Canine adenoviral vectors: An alternative for adenovirus-mediated gene transfer. J. Virol. 74, 505-512.
10. LOUIS, N., EVELEGH, C., and GRAHAM, F.L. (1997). Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233, 423-429.
11. MITTAL, S.K., PREVEC, L., GRAHAM, F.L., and BABIUK, L.A. (1995). Development of a bovine adenovirus type 3-based expression vector. J. Gen. Virol. 76, 93-102.
12. ROBERT, J.J., GAUFFENY, I., MACCARIO, J., JULLIEN, C., BENOIT, P., VIGNE, E., CROUZET, J., PERRICAUDET, M., and YEH, P. (2001). Degenerated pIX-IVa2 adenoviral vector sequences lower reacquisition of the E1 genes during virus amplification in 293 cells. Gene Ther. 8, 1713-1720.
13. ROGERS, N.G., BASNIGHT, M., GIBBS, C.J., and GAJDUSEK, D.C. (1967). Latent viruses in chimpanzees with experimental kuru. Nature 216, 446-449.
14. SHIVER, J. (2003). A non-replicating adenoviral vector as a potential HIV vaccine. Res. Initiat. Treat. Action 8, 14-16.
15. SULLIVAN, N.J., SANCHEZ, A., ROLLIN, P.E., YANG, Z.Y., and NABEL, G.J. (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605-609.
16. SULLIVAN, N.J., GEISBERT, T.W., GEISBERT, J.B., XU, L., YANG, Z.Y., ROEDERER, M., KOUP, R.A., JAHRLING, P.B., and NABEL, G.J. (2003). Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424, 681-684.
17. TIMS, T., BRIGGS, D.J., DAVIS, R.D., MOORE, S.M., XIANG, Z., ERTL, H.C., and FU, Z.F. (2000). Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. Vaccine 18, 2804-2807.
18. VOGELS, R., ZUIJDGEEST, D., VAN RIJNSOEVER, R., HARTKOORN, E., DAMEN, I., DE BETHUNE, M.P., KOSTENSE, S., PENDERS, G., HELMUS, N., KOUDSTAAL, W., CECCHINI, M., WETTERWALD, A., SPRANGERS, M., LEMCKERT, A., OPHORST, O., KOEL, B., VAN MEERENDONK, M., QUAX, P., PANITTI, L., GRIMBERGEN, J., BOUT, A., GOUDSMIT, J., and HAVENGA, M. (2003). Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: Efficient human cell infection and bypass of preexisting adenovirus immunity. J. Virol. 77, 8263-8271.
19. WALDMAN, A.S., and LISKAY, R.M. (1988). Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology. Mol. Cell. Biol. 8, 5350-5357.
20. WIVEL, N.A., GAO, G.P., and WILSON, J.M. (1999). Adenoviral vectors. In The Development of Human Gene Therapy. T. Friedman, ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 87-110.
21. XIANG, Z.Q., YANG, Y., WILSON, J.M., and ERTL, H.C. (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219, 220-227.
22. XIANG, Z., GAO, G., REYES-SANDOVAL, A., COHEN, C.J., LI, Y., BERGELSON, J.M., WILSON, J.M., and ERTL, H.C. (2002). Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J. Virol. 76, 2667-2675.
23. XU, Z.Z., HYATT, A., BOYLE, D.B., and BOTH, G.W. (1997). Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology 230, 62-71.